Archiv der Pharmazie p. 233 - 234 (1997)
Update date:2022-08-05
Topics: Synthesis NMR spectroscopy Mass spectrometry Reaction Conditions In vitro assay Bone resorption
Pifferi, Giorgio
Da Re, Paolo
Valenti, Piero
Bisi, Alessandra
Malandrino, Salvatore
A topological modification of ipriflavone 1, a recent antiosteoporotic drug, is described, The flavone moiety of 1 has been replaced by a xanthone one, Among the new derivatives, the 3,6-diisopropoxyxanthone (2a) has shown significant bone resorption inhibition in in vitro and in vivo tests.
View MoreChangsha Huajing Powdery Material Technological Co., Ltd.
Contact:86-731-88879686
Address:Building 2, West Garden, Main Campus of Central South University, Changsha, Hunan Province, China
Shanghai Pengkai Chemical Co.,Ltd
Contact:+86-21-60526671
Address:No.4226 Duzhuang Rd Minhang District Shanghai China
Hangzhou Eastbiopharm Co.,Ltd.
Contact:+86-571-88931780
Address:Hangzhou,China
Suzhou Kangrun Pharmaceutical, Inc
Contact:86-512-63912376，63913329
Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Anhui Jiatiansen Agrochemical Co.,Ltd
Contact:15366811918
Address:chemical industrial park,xiangyu town,dongzhi county,anhui,china
Doi:10.1002/jps.2600650319
(1976)Doi:10.1021/ja00422a036
(1976)Doi:10.1021/ja01566a077
(1957)Doi:10.1139/v00-113
(2000)Doi:10.1021/jo034447c
(2003)Doi:10.1021/jacs.1c05852
(2021)
